The Institute of Cancer Research, London, is one of the world’s most 
influential cancer research institutes, with an outstanding record of 
achievement dating back more than 100 years. We provided the first convincing 
evidence that DNA damage is the basic cause of cancer, laying the foundation 
for the now universally accepted idea that cancer is a genetic disease. Today, 
The Institute of Cancer Research (ICR) leads the world at isolating 
cancer-related genes and discovering new targeted drugs for personalised cancer 
treatment.

The Cancer Research UK Cancer Therapeutics Unit (CTU), within the Division of 
Cancer Therapeutics, is a multidisciplinary 'bench to bedside' centre, 
comprising around 160 staff dedicated to the discovery and development of novel 
therapeutics for the treatment of cancer. The CTU’s exciting goal is to 
discover high quality small molecule drug candidates and to progress these to 
clinical trial. All the scientific disciplines are in place to make this 
possible, including assay development and screening, medicinal chemistry, 
biology, structural biology, metabolism and clinical specialists.
Two postdoctoral positions in Structural Biology (ID 758) are available in Dr 
Rob van Montfort’s Hit Discovery and Structural Design (HDSD) Team within the 
CTU.

The postdoctoral researchers in structural biology will be involved in X-ray 
crystallography, fragment-based screening and structure-based drug design and 
will be responsible for protein expression, purification, crystallisation, 
structure determination and structural analysis of protein-ligand complexes 
from one of the CTU’s drug discovery programmes. The successful candidates will 
also be part of the Division of Structural Biology, in which the 
crystallographers in Dr van Montfort’s team are embedded, and will have access 
to state of the art protein crystallography and electron microscopy facilities, 
including an in-house X-ray source and excellent access to synchrotrons. The 
successful candidate will interact closely with the biology, computational 
chemistry and medicinal chemistry teams at the CTU, and will therefore be 
expected to work across the two sites in Chelsea, London and Sutton, Surrey. 
Applicants must have a PhD in a biological or physical science, and experience 
in macromolecular crystallography (to include protein biochemistry, protein 
crystallisation, & protein crystallography). Experience in molecular biology, 
protein expression in insect cells, structure-based drug design, and/or 
biophysics will be an advantage. The starting salary for the positions will be 
in the range £31,023 to £39,473 p.a. inclusive (based on previous post-doctoral 
experience). One position is funded for one year and one is funded for two 
years. Applicants will automatically be considered for both positions. Informal 
enquiries can be made via email to 
rob.vanmontf...@icr.ac.uk<mailto:rob.vanmontf...@icr.ac.uk> or 
yann-vai.lebi...@icr.ac.uk<mailto:yann-vai.lebi...@icr.ac.uk>. Closing date is 
07/07/2019.

Please DO NOT send your application to Dr van Montfort, or Dr Le Bihan. 
Applications will only be considered if made via the e-recruitment system on 
our website www.icr.ac.uk<http://www.icr.ac.uk>.

Dr. Rob van Montfort
Team Leader Hit Discovery and Structural Design
Divisions of Cancer Therapeutics and Structural Biology
The Institute of Cancer Research
15 Cotswold Road
Sutton SM2 5NG
UK

Tel:
+44-(0)20-8722-4364 (Sutton)
+44-(0)20-7153-5142 (Chelsea)
Email: rob.vanmontf...@icr.ac.uk<mailto:rob.vanmontf...@icr.ac.uk>








The Institute of Cancer Research: Royal Cancer Hospital, a charitable Company 
Limited by Guarantee, Registered in England under Company No. 534147 with its 
Registered Office at 123 Old Brompton Road, London SW7 3RP.

This e-mail message is confidential and for use by the addressee only.  If the 
message is received by anyone other than the addressee, please return the 
message to the sender by replying to it and then delete the message from your 
computer and network.


########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1

Reply via email to